Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder-Reference-Cited by-同舟云学术

Assessment of Psilocybin Therapy for Patients With Cancer and Major Depression Disorder

Published:2023-06-01 Issue:6 Volume:9 Page:864
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Agrawal Manish¹,Emanuel Ezekiel²³,Richards Brian¹⁴,Richards William¹⁴,Roddy Kim¹,Thambi Paul¹⁴

Affiliation:

1. Sunstone Therapies, Rockville, Maryland

2. Department of Medical Ethics and Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia

3. Department of Healthcare Management, The Wharton School, University of Pennsylvania, Philadelphia

4. Aquilino Cancer Center, Maryland Oncology Hematology, Rockville

Abstract

This nonrandomized controlled trial used a 1-to-1 therapist-to-patient ratio to administer psilocybin to groups of patients with cancer who were diagnosed with major depression disorder to create a scalable, rapidly effective depression treatment.

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

https://jamanetwork.com/journals/jamaoncology/articlepdf/2803623/jamaoncology_agrawal_2023_ld_230005_1686773072.5477.pdf

Reference6 articles.

1. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies.;Mitchell;Lancet Oncol,2011

2. Association of depression and anxiety on quality of life, treatment adherence, and prognosis in patients with advanced non-small cell lung cancer.;Arrieta;Ann Surg Oncol,2013

3. Efficacy and safety of pharmacotherapy in cancer-related psychiatric disorders across the trajectory of cancer care: a review.;Grassi;Int Rev Psychiatry,2014

4. Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial.;Griffiths;J Psychopharmacol,2016

5. The Quick Inventory of Depressive Symptomatology-Self-Report: a psychometric evaluation in patients with asthma and major depressive disorder.;Brown;Ann Allergy Asthma Immunol,2008

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of GluN2B-Containing NMDA receptor antagonist for antitumor and antidepressant therapy in non-small cell lung cancer;European Journal of Pharmacology;2024-10

2. The role of psilocybin in depressive disorders;Current Medical Research and Opinion;2024-08-28

3. Errors in Table;JAMA Oncology;2024-08-01

4. Increased reactivity of the paraventricular nucleus of the hypothalamus and decreased threat responding in male rats following psilocin administration;Nature Communications;2024-06-22

5. Ethische Aspekte der Therapie mit Psychedelika;Die Psychotherapie;2024-02-09